换一批白细胞介素23抑制剂古塞奇尤单抗在银屑病治疗中的应用
Application of the interleukin-23 inhibitor guselkumab in the treatment of psoriasis
摘要古塞奇尤单抗作为首个靶向白细胞介素23的抑制剂，在多项随机对照临床试验中对中重度银屑病患者的治疗显示出良好的疗效和安全性，能显著改善患者的生活质量。本文综述白细胞介素23和其抑制剂的作用机制及在银屑病治疗中的应用。
更多相关知识
abstractsGuselkumab is the first monoclonal antibody that selectively targets interleukin (IL) -23. Several randomized controlled clinical trials have demonstrated that it is highly effective and safe in the treatment of moderate to severe plaque psoriasis, and can significantly improve the quality of life of patients. This review summarizes the action mechanisms of IL-23 and guselkumab, as well as the application of guselkumab in the treatment of psoriasis.
More相关知识
栏目名称
DOI
10.35541/cjd.20200712
发布时间
2023-02-15（万方平台首次上网日期，不代表论文的发表时间）
- 浏览95
- 被引4
- 下载23
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
